Lucy Hicks is a reporter for Medscape and MDEdge, with her work also appearing in The Lancet. She specializes in covering topics related to rheumatology, including advancements in treatment, research findings, and the impact on patient care. Her articles aim to provide healthcare professionals with the latest information and insights in the field of rheumatology.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Lucy's extensive coverage of healthcare and pharmaceutical topics with a strong emphasis on citing data indicates that she is likely to respond well to pitches providing in-depth analysis or insights supported by robust scientific evidence. Given her focus on rheumatology, pediatric rheumatology, and related areas, experts who can provide detailed information about these fields would be particularly valuable for her articles.
With Lucy's broad topic coverage and substantial use of data citations, it appears that she takes an international approach rather than focusing on specific geographic regions. Therefore, approaches from global sources with relevant expertise are likely to resonate well with her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
November 4, 2024 | Rheumatology News With the discovery of autoantibodies and other risk factors for rheumatoid
The American College of Rheumatology (ACR) 2024 Annual Meeting is coming up in Washington, DC.
WASHINGTON — Patients with granulomatosis with polyangiitis (GPA) completely tapered off prednisone have a more than fourfold risk of relapse by 6
WASHINGTON — A diagnostic test to predict preeclampsia does not effectively rule in or out this pregnancy complication in women with systemic lupus
The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.
More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the historical comparison group.
WASHINGTON — Women with rheumatoid arthritis (RA) experience improved fertility when treated using a treat-to-target (T2T) approach aimed at remission, according to a new research presented at the annual meeting of the American College of Rheumatology.
WASHINGTON — A diagnostic test to predict preeclampsia does not effectively rule in or out this pregnancy complication in women with systemic lupus erythematosus (SLE) and proteinuria, according to new research presented at the annual meeting of the American College of Rheumatology (ACR).
The novel therapy, delivered via implantable, pill-sized device, improved RA signs and symptoms in patients receiving daily stimulation.
WASHINGTON — An implantable vagus nerve stimulation (VNS) device effectively treats moderate to severe rheumatoid arthritis (RA) in patients who
(833) 317-6278 
